United Therapeutics FDA accepts ralinepag NDA, sets June 24, 2027 PDUFA
United Therapeutics says the FDA accepted its New Drug Application for ralinepag to treat pulmonary arterial hypertension and set a PDUFA date of June 24, 2027.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.